Ritonavir boosted indinavir treatment as a simplified maintenance 'mono'-therapy for HIV infection

AIDS

Volumn 18, Issue 6, 2004, Pages 955-957

  Kahlert, Christian ^a,b   Hupfer, Maria ^a   Wagels, Thomas ^a   Bueche, Daniel ^a   Fierz, Walter ^b   Walker, Ulrich A ^c   Vernazza, Pietro L ^a  

^a CANTONAL HOSPITAL ST GALLEN   (Switzerland)

^b Inst Clin Microbiol and Immunol   (Switzerland)

^c UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INDINAVIR; RITONAVIR;

ARTICLE; CLINICAL ARTICLE; DUAL ENERGY X RAY ABSORPTIOMETRY; FEASIBILITY STUDY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MONOTHERAPY; NEPHROTOXICITY; PRIORITY JOURNAL; T CELL LYMPHOMA; UROLITHIASIS;

ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1; HUMANS; INDINAVIR; MALE; PILOT PROJECTS; REVERSE TRANSCRIPTASE INHIBITORS; RITONAVIR; RNA, VIRAL;

EID: 2142694373     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-200404090-00017     Document Type: Article

References (7)

1. Havlir DV, Marschner IC, Hirsch MS, Collier AC, Tebas P, Bassett RL, et al. Maintenance antiretroviral therapies in HIV-infected subjects with undetectable plasma HIV RNA after triple-drug therapy. N Engl J Med 1998; 339:1261-1268.
2. Moyle G. Use of HIV protease inhibitors as pharmacoenhancers. AIDS Reader 2000, 11:87-98.
3. Vernazza PL, Kashuba DM, Cohen MS. Biological correltaes of sexual transmission of HIV: practical consequences and potential targets for public health. Rev Med Microbiol 2001, 12: 131-142.
4. van Praag R, Weverling GJ, Portegies P, Jurriaans S, Zhou XJ, Turner-Foisy ML, et al. Enhanced penetration of indinavir in cerebrospinal fluid and semen after the addition of low-dose ritonavir. AIDS 2000, 14:1187-1194.
5. Montaner J, Hill A, Acosta E. Practical implications for the interpretation of minimum plasma concentration/inhibitory concentration ratios. Lancet 2001, 357:1438-1440.
6. Schockmel GA, Yerly S, Perrin L. Detection of low HIV-1 RNA levels in plasma. J Acquired Immune Defic Syndr Hum Retrovirol 1997, 14:179-183.
7. Solas C, Lafeuillade A, Halfon P, Chadapaud S, Hittinger G, Lacarelle B. Discrepancies between protease inhibitor concentrations and viral load in reservoirs and sanctuary sites in human immunodeficiency virus-infected patients. Antimicrob Agents Chemother 2003, 47:238-243.